Yann Godfrin
Lyon, 69008, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
NX210c Demonstrates Therapeutic Potential to Restore Blood-Brain Barrier in a QSP Model of Relapsing-Remitting Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: December 23, 2025
Administration of a Novel Peptide Derived From Thrombospondin Repeat Sequences Enhances Recovery after Cervical Spinal Cord Injury.
Journal: Journal of neurotrauma
Published: December 03, 2025
Zinc Isotope Fingerprints in Juvenile Fishes from Estuarine Nurseries with Different Pollution Histories: Perspectives for Environmental Monitoring and Fish Ecology.
Journal: Environmental science & technology
Published: November 24, 2025
SCO-Spondin-Derived Peptide NX210 Promotes Functional Recovery after Spinal Cord Injury in Mice.
Journal: Journal of neurotrauma
Published: July 18, 2025
Smart zwitterionic biodegradable hydrogel for sustained peptide delivery: Application to the neurotherapeutic peptide NX210c.
Journal: Biomaterials advances
Published: June 13, 2025
Restoring brain barriers: an innovative approach for treating neurological disorders.
Journal: Fluids and barriers of the CNS
Published: May 20, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual Patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 15, 2025
Focus on therapeutic peptides and their delivery.
Journal: International journal of pharmaceutics
Published: February 07, 2025
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.
Journal: Neurology and therapy
Published: October 09, 2024
NX210c drug candidate peptide strengthens mouse and human blood-brain barriers.
Journal: Fluids and barriers of the CNS
Published: June 05, 2024
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System.
Journal: International journal of molecular sciences
Published: June 28, 2022
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.
Journal: Neurology and therapy
Published: April 26, 2022
Last Updated: 09/26/2026